Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals

Joseph Yeboah1, Robyn L McClelland, Tamar S Polonsky

  • 1Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. jyeboah@wakehealth.edu

JAMA
|August 23, 2012
PubMed

Insights

Coronary artery calcium (CAC) best predicts coronary heart disease (CHD) risk in intermediate-risk individuals. CAC significantly improved risk prediction compared to other markers like ankle-brachial index and C-reactive protein.

Area of Science:

  • Cardiovascular disease research
  • Biomarker analysis
  • Risk stratification

Background:

  • Established risk markers for coronary heart disease (CHD) exist, but direct comparisons for improving the Framingham Risk Score (FRS) are lacking.
  • Intermediate-risk individuals (FRS 5%-20%) require refined risk prediction models.

Purpose of the Study:

  • To compare the predictive performance of six risk markers for incident CHD and cardiovascular disease (CVD).
  • To evaluate the incremental value of these markers when added to the FRS in intermediate-risk participants.

Main Methods:

  • The Multi-Ethnic Study of Atherosclerosis (MESA) cohort included 1330 intermediate-risk participants without diabetes.
  • Six risk markers were assessed: coronary artery calcium (CAC), carotid intima-media thickness (CIMT), ankle-brachial index (ABI), brachial flow-mediated dilation (FMD), high-sensitivity C-reactive protein (hs-CRP), and family history of CHD.
  • Cox proportional hazard models, AUC, and net reclassification improvement (NRI) were used for analysis.

Main Results:

  • CAC, ABI, hs-CRP, and family history were independently associated with incident CHD.
  • CAC demonstrated the highest improvement in AUC (0.784 vs. 0.623) and the greatest NRI (0.659) for CHD prediction.
  • CIMT and FMD did not show significant associations with incident CHD in multivariable analyses.

Conclusions:

  • CAC, ABI, hs-CRP, and family history are independent predictors of CHD/CVD in intermediate-risk populations.
  • Coronary artery calcium offers superior discrimination and risk reclassification compared to other evaluated risk markers.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
781
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
913
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468